| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research | C/O SURROZEN, INC., 171 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO | /s/ Charles Williams, Attorney-in-Fact for Yang Li | 16 Dec 2025 | 0001990537 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SRZN | Common Stock | Award | $13,511 | +1,666 | +13% | $8.11 | 14,709 | 15 Dec 2025 | Direct | F1 |
| holding | SRZN | Common Stock | 351 | 15 Dec 2025 | By Daughter | ||||||
| holding | SRZN | Common Stock | 351 | 15 Dec 2025 | By Son |
| Id | Content |
|---|---|
| F1 | This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |